Article: Research Triangle Park tech firm may have created new type of inhaler.

Byline: Jeff Zimmer

Feb. 8--The founders of Oriel Therapeutics think they've created a next-generation device for treating respiratory diseases -- an inhaler that uses an electronic signal to deliver medicines to the lungs.

The 3-year-old Research Triangle Park company is built around technology developed in UNC School of Pharmacy labs in the 1990s. It was there that Timm Crowder and Anthony Hickey took on the heady question of understanding how dry powder moves.

While the question sounds academic, Crowder and Hickey thought the answer would provide a window -- or oriel -- into how to better control the flow of medicines that are in dry powder ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!